LATEST NEWS

January, 2012

New Viriathus Healthcare Report Covers iSonea, January, 2012

iSonea to present at Cappello Capital Corp Investor Conference

New Issue Announcement,
Application for Quotation of Additional Securities and Agreement

iSonea Limited Commences Trading on the U.S. OTCQX International

iSonea Limited Announces Publication of Initial Viriathus Research Report

December, 2011

iSonea receives Subscriptions under Rights Issue...

Shareholders Top 20 Listing

Notice of change of interests of substantial holder (RB)

Appendix 3Y: Change of Director’s Interest Notice (RH)

Notice of ceasing to be a substantial holder

Appendix 3Y: Change of Director’s Interest Notice (JK)

© 2012 iSonea (formerly Karmelsonix) Ltd| Disclaimer, Terms and Conditions, Copyright and Intellectual Property.

BlackFin® Processor

iSonea ISO Certification 2003

US Food & Drug Administration

Australian Government Therapeutic Goods Administration

CE Certification